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Abstract
Background: Fetal	growth	restriction	is	associated	with	higher	risks	of	childhood	res‐
piratory	morbidity.	Fetal	blood	flow	adaptations	might	contribute	to	these	associa‐
tions.	We	examined	the	associations	of	fetal	umbilical,	cerebral,	and	pulmonary	blood	
flow with wheezing patterns, lung function, and asthma in childhood.
Methods: In a population‐based prospective cohort study among 903 children, we 
measured fetal umbilical, cerebral, and pulmonary blood flow by pulsed‐wave 
Doppler	at	a	median	gestational	age	of	30.3	(95%	range	28.8‐32.3)	weeks.	We	ob‐
tained information about wheezing patterns until the age of 6 years by question‐
naires. Lung function was measured by spirometry and information about current 
asthma was obtained by questionnaire at the age of 10 years.
Results: Results showed a non‐significant relationship between a higher umbilical 
artery	pulsatility	index	(PI)	and	umbilical	artery	PI/cerebral	artery	PI	ratio,	indicating	
fetal	blood	flow	redistribution	at	the	expense	of	the	trunk,	with	higher	risks	of	early	
wheezing (OR [95% CI]: 2.07 (0.70‐6.10) and 2.74 (0.60, 12.62) per unit increase, re‐
spectively). A higher pulmonary artery time velocity integral, indicating higher pul‐
monary vascular resistance, was associated with a higher risk of late/persistent 
wheezing (Z‐score 1.14 [1.01‐1.29]). A higher middle cerebral artery PI was associated 
with	a	higher	FEV1/FVC	(Z‐score	[95%	CI]:	0.21	[0.01‐0.42]).	Results	did	not	materi‐
ally change after additional adjustment for birth and growth characteristics.
Conclusion: Third‐trimester fetal blood flow patterns might be related to childhood 
respiratory health. These findings should be considered as hypothesis generating and 
need further replication.
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1  | INTRODUC TION
Pregnancy is a critical period for fetal lung development. In late fetal 
life, the small airways and alveoli are formed.1 An adverse intrauter‐
ine environment in this period seems to have persistent effects on 
respiratory health and disease across the life course.2	 Fetal	 blood	
flow adaptations are important mechanisms by which the fetus pro‐
tects the most important organs such as the brain and heart from 
an adverse fetal environment.3 A preferential fetal blood flow to the 
brain	at	the	expense	of	the	trunk	is	characterized	by	changes	in	fetal	
blood flow including a higher umbilical and lower cerebral arterial 
resistance.4,5 This redistribution of fetal blood flow may be beneficial 
for	short‐term	survival	but	may	 lead	to	a	 lower	delivery	of	oxygen	
and nutrients to the trunk, including the lungs and airways.6,7 A po‐
tential consequence of fetal blood flow redistribution is a reduction 
in number and metabolism of alveolar type II cells, fewer but larger 
alveoli, and impaired growth and maturation of the airways and 
lungs.8,9 Impaired fetal development of the airways and lungs could 
predispose individuals to a higher risk of lung disease in later life.8 
Previous studies reported associations of fetal growth restriction 
with impaired lung function and respiratory diseases in later life.10,11 
We	previously	showed	that	fetal	growth	restriction	and	being	born	
small for gestational age were associated with higher airway re‐
sistance and lower lung function in childhood.12	 Fetal	 blood	 flow	
adaptations related to fetal growth restriction may underlie these as‐
sociations. Although the effects of fetal umbilical and cerebral blood 
flow adaptations on fetal and childhood growth are well known, it 
is unknown whether fetal blood flow adaptations affect childhood 
respiratory morbidity. Also, the role of a suboptimal fetal pulmonary 
blood flow on the development of respiratory morbidity is unclear.
Therefore,	we	examined	 in	a	population‐based	prospective	co‐
hort study among 903 children the associations of fetal umbilical, 
cerebral, and pulmonary blood flow with wheezing at age 6 years, 
and	lung	function	and	asthma	in	children	aged	10	years.	We	also	ex‐
plored whether birthweight, gestational age at birth, or childhood 
growth mediated these associations.
2  | METHODS
2.1 | Design and study population
This study was embedded in the Generation R Study, a population‐
based prospective cohort study from fetal life onward in Rotterdam, 
the Netherlands.13 The Medical Ethics Committee of the Erasmus 
MC, University Medical Center, Rotterdam, has approved the study. 
Written	 informed	 consent	 was	 obtained	 from	 all	 participants.	
Detailed assessments of fetal growth and development were con‐
ducted in a random subgroup of 1232 Dutch mothers and children 
born	between	April	2002	and	January	2006.4 The present analyses 
were	performed	on	903	children	(Figure	1).
2.2 | Third‐trimester fetal blood flow
Fetal	blood	flow	measures	were	assessed	by	pulsed‐wave	Doppler	
at a median gestational age of 30.3 (95% range 28.8‐32.3) weeks.
Feto‐placental	vascular	resistance	was	evaluated	with	recorded	
flow‐velocity waveforms from the umbilical artery. Umbilical artery 
pulsatility	 index	 (PI)	was	determined	 in	 a	 free‐floating	 loop	of	 the	
umbilical cord. A higher umbilical artery PI indicates a higher periph‐
eral vascular resistance.14 Middle cerebral artery Doppler measure‐
ments	were	 performed	with	 visualization	 of	 the	 circle	 of	Willis	 in	
the fetal brain, and flow‐velocity waveforms were obtained in the 
proximal	part	of	the	cerebral	arteries.	The	middle	cerebral	artery	PI	
quantifies the redistribution of blood flow, and when lower, in favor 
of the fetal brain. Reductions in middle cerebral artery PI are valid 
indicators of the brain‐sparing effect and fetal redistribution.15 An 
indicator of the “brain‐sparing effect” is a raised ratio between the 
umbilical artery PI and the cerebral artery PI (U/C ratio).5.
Pulmonary outflow flow‐velocity waveforms from the aorta 
were	recorded	from	the	five‐chamber	view	and	the	short‐axis	view	
of the fetal heart just above the semilunar valves. Time velocity in‐
tegral (TVI) during systole was recorded. A higher pulmonary artery 
TVI indicated higher pulmonary vascular resistance.16.
K E Y W O R D S
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Key Message
An adverse intrauterine environment may have conse‐
quences on respiratory health and disease across the life 
course.	We	assessed	whether	fetal	blood	flow	adaptations	
are related to lung function development and asthma risk in 
childhood. Non‐significant tendencies towards associations 
for fetal blood flow redistribution with higher risk of early 
wheezing were found, a higher pulmonary vascular resist‐
ance was associated with higher risk of late/persistent 
wheezing.	This	study	is	the	first	that	examines	these	asso‐
ciations. Our findings are important from an etiological and 
developmental perspective, providing evidence that 
changes in fetal blood patterns may lead to altered respira‐
tory health.
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Reproducibility of ultrasound measurements was adequate 
with high intraclass correlation coefficient values (>0.80) with cor‐
responding low variation coefficient values (<10%).4 All ultrasound 
examinations	were	performed	with	an	ATL‐Philips	model	HDI	5000	
(Seattle,	 Washington,	 USA)	 equipped	 with	 a	 5.0‐MHz	 high‐fre‐
quency, curved‐array transducer.
2.3 | Childhood lung function and asthma
Information about wheezing was obtained by questionnaires until 
6	years.	We	constructed	wheezing	patterns	based	on	time	of	onset	
and	 subsequent	 absence	 or	 persistence	 (“never”;	 “early”	 [≤3	years	
only]; “late” [>3‐6 years] and “persistent wheezing”) in children with 
information on wheezing for at least two time points.17 Children 
visited the research center at a median age of 9.7 years (range 
8.5‐12.0	years),	 and	 we	 performed	 spirometry:	 forced	 expiratory	
volume	 in	1	second	 (FEV1),	 forced	 vital	 capacity	 (FVC),	 and	FEV1/
FVC.	Spirometry	was	performed	according	to	the	American	Thoracic	
Society and European Respiratory Society recommendations.18 All 
spirometry	variables	were	converted	into	sex‐,	age‐,	height‐,	and	eth‐
nicity‐adjusted z‐scores.19 Current asthma (no; yes) was defined as 
physician‐diagnosed asthma ever, with either wheezing or the use 
of (airway) medication in the past 12 months by questionnaires at 
age 10 years.
2.4 | Covariates
We	obtained	 information	on	maternal	 educational	 level,	 pre‐preg‐
nancy weight, parity, smoking during pregnancy, folic acid use 
during pregnancy, and history of asthma or atopy, from question‐
naires. Maternal height was measured and pre‐pregnancy BMI was 
calculated (kg/m2). Estimated fetal weight in the third trimester was 
calculated.20 Information on gestational hypertensive disorders, 
child's	 sex,	 gestational	 age	 at	 birth,	 and	birthweight	was	obtained	
by midwife and hospital registries. At age 10 years, information on 
ever diagnosis of eczema was obtained by questionnaire. During the 
research center visit at age 10 years, child height and weight were 
measured	using	Standard	Operating	Procedures.	We	measured	the	
children without shoes and heavy clothing, and BMI was calculated. 
Allergic sensitization to the most common inhalant allergens (house 
dust mite, grass, birch, cat, and dog; ALK‐Abelló BV, Almere, The 
Netherlands) was determined by a skin prick test using the “scanned‐
area method.”21.
2.5 | Statistical analysis
First,	 we	 performed	 a	 non‐response	 analysis	 by	 assessing	 the	
differences in characteristics of participants included and not in‐
cluded in the study. Second, we assessed the associations of fetal 
blood flow with wheezing patterns, lung function, and asthma 
using multivariate logistic or linear regression models. These 
models were first adjusted for gestational age at third‐trimes‐
ter fetal blood flow measurement and estimated fetal weight at 
third‐trimester	 fetal	 blood	 flow	 measurement	 or	 child	 sex	 only	
(basic model), and secondly, additionally adjusted for maternal 
educational level, pre‐pregnancy BMI, parity, smoking, folic acid 
use,	and	gestational	hypertensive	disorders	(adjusted	model).	We	
used	generalized	estimating	equations	(GEEs)	to	examine	longitu‐
dinal effects of fetal blood flow with the risk of overall wheezing 
until age 6 years. These models take into account the correla‐
tions between repeated measurements within the same subject. 
An	unstructured	correlation	matrix	was	used.	Third,	we	examined	
whether any association of fetal blood flow with wheezing pat‐
terns, lung function, or asthma was mediated by birthweight or 
gestational age at birth or child's BMI at age 10 years by adding 
them	additionally	 in	our	models	 (mediation	model).	Furthermore,	
we	examined	whether	maternal	history	of	asthma	or	atopy,	child's	
eczema, or inhalant allergic sensitization modified any association 
by analyzing the statistical interaction between these variables 
and	 the	 fetal	 blood	 flow–related	 exposures	 (effect	modification	
F I G U R E  1  Flowchart	of	participants	
included in the analysis
n = 1215
Singleton live births participating in the 
Generation R subgroup
n = 19 
Excluded due to missing fetal blood flow 
measurements 
n = 903
Children with information on any childhood 
lung function measure or asthma  
Wheezing n = 742
FEV1 n = 785
FVC n = 785
FEV1/FVC n = 785
Current asthma n = 834
n = 1195
Data on fetal blood flow distribution 
n = 292 
Excluded due to missing lung function 
measurements or asthma information 
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model). The percentages of missing covariate values within the 
population for analysis were lower than 19%. Missing covariate 
data were imputed using the multiple imputations procedure (n = 5 
imputations), and the imputed datasets were analyzed together. 
All measures of associations are presented with their 95% con‐
fidence intervals (CI). Statistical analyses were performed using 
SPSS	version	24.0	for	Windows	(SPSS	Inc,	Chicago,	Illinois,	USA).
3  | RESULTS
3.1 | Participant characteristics
Table 1 shows the characteristics of the mothers and children in‐
cluded in the current study. Table S1 shows the participant charac‐
teristics before multiple imputation. Non‐response analyses showed 
that mothers of children not included in the analysis were more 
frequently lower educated, had a higher prevalence of multiparity, 
smoked more often, and used less often folium acid supplement dur‐
ing pregnancy. Their children were born at a younger gestational age 
(Table S2).
3.2 | Fetal blood flow and wheezing patterns until 
age 6 years
Table 2 shows, in the adjusted models, a non‐significant relationship 
between a higher umbilical artery PI with higher risks for early and 
late/persistent wheezing in children (odds ratio [OR] 2.07 [95% CI, 
0.70, 6.10] and 1.68 [0.34, 6.50] per unit increase in umbilical artery 
PI, respectively). Similarly, a higher U/C ratio, which indicates redis‐
tribution of blood flow in favor of the fetal brain, tended to be as‐
sociated with a higher risk for early wheezing (OR, 2.74 [0.60, 12.62] 
per unit increase in U/C ratio). None of these associations were sta‐
tistically significant. Middle cerebral artery PI was not associated 
with wheezing patterns. A higher pulmonary artery TVI, which in‐
dicates higher pulmonary vascular resistance, was associated with a 
higher risk of late or persistent wheezing (OR, 1.14 [1.01, 1.29] per 
unit increase in pulmonary artery TVI). The effect estimates for the 
associations of fetal umbilical, cerebral, and pulmonary blood flow 
adaptations with wheezing patterns adjusted for gestational age 
at	third	trimester,	estimated	fetal	weight,	and	child	sex	only	 (basic	
model) were similar as for the adjusted models, and are presented 
in Table S3.
3.3 | Fetal blood flow and lung function and asthma 
at age 10 years
Table 3 shows that in the adjusted models, a higher third‐trimester 
fetal	middle	cerebral	artery	PI	was	associated	with	a	higher	FEV1/
FVC	only	(Z‐score,	0.21	[95%	CI,	0.01,	0.42]	per	unit	increase	mid‐
dle	cerebral	artery	PI).	We	observed	no	consistent	associations	of	
fetal blood flow with other lung function measures. Results from 
the models focused on these associations adjusted for gestational 
age	 at	 third	 trimester,	 estimated	 fetal	weight,	 and	 child's	 sex	only	
TA B L E  1   Characteristics of children and their mothers after 
multiple imputation (n = 903)
 Study population
Maternal characteristics
Education (%)
Low (no, primary, second‐
ary education)
32.9 (297)
High (higher education) 67.1 (606)
Pre‐pregnancy body mass 
index	(kg/m2)
23.6 (3.9)
Parity (%)
Nullipara 62.8 (567)
Multipara 37.2 (336)
History of asthma or atopy (%)
No 61.7 (557)
Yes 38.2 (346)
Smoking during pregnancy (%)
No smoking throughout 
pregnancy
79.1 (714)
Yes 20.9 (189)
Folic	acid	supplement	use	(%)
No use 8.2 (74)
Start within the first 10 wk 
of pregnancy
29.3 (265)
Preconceptional start 62.5 (564)
Pregnancy‐induced complications (gestational hypertension/
preeclampsia) (%)
No 91.7 (828)
Yes 8.3 (75)
Third‐trimester fetal characteristics
Gestational age at measure‐
ment, wk
30.4 (28.5‐32.7)
Estimated fetal weight, grams 1632 (266)
Umbilical artery PI 0.97 (0.16)
Middle cerebral artery PI 1.97 (0.33)
Umbilical/middle cerebral 
artery ratio
0.50 (0.11)
Pulmonary artery time 
velocity integral
12.04 (1.83)
Birth characteristics
Gestational age at birth, wk 40.3 (36.7‐42.4)
Birthweight, g 3528 (509)
Sex
Male 50.6 (457)
Female 49.4 (446)
Childhood characteristics
Wheezing	patterns	until	6	y	(%)
Never 45.8 (414)
Early 23.0 (208)
(Continues)
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(basic model) showed no associations of fetal umbilical, cerebral, and 
pulmonary blood flow with lung function or asthma at age 10 years 
(Table S4).
Results of the associations of fetal umbilical, cerebral, and pul‐
monary blood flow with wheezing patterns, lung function, or asthma 
did not materially change after adding the mediators birthweight, 
gestational age at birth, or BMI at age 10 years (mediation model, 
data not shown). The associations were not modified by maternal 
history of asthma or atopy or child's eczema or inhalant allergic 
sensitization (effect modification model, all P‐values for interaction 
>0.05).
4  | DISCUSSION
We	observed	a	non‐significant	 relationship	between	a	higher	um‐
bilical artery PI and U/C ratio with higher risk of early and late/
persistent wheezing. A higher pulmonary artery TVI was associ‐
ated	with	a	higher	risk	of	late/persistent	wheezing.	We	found	that	a	
higher	middle	cerebral	artery	PI	was	associated	with	a	higher	FEV1/
FVC.	Associations	were	not	explained	by	birth	parameters,	current	
BMI, or allergic predisposition. No other consistent associations of 
changes in fetal umbilical, cerebral, or pulmonary blood flow with 
wheezing patterns until age 6 years, or lung function and asthma at 
age 10 years, were found.
4.1 | Interpretation and comparison with 
previous studies
An adverse intrauterine environment in the developing fetus leads 
to fetal blood flow adaptations. These adaptations may be beneficial 
for	short‐term	survival	but	may	lead	to	a	 lower	delivery	of	oxygen	
and nutrients to the trunk.6	 Fetal	 blood	 flow	 adaptations	 can	 be	
detected by umbilical vein blood flow. A compensatory increase in 
ductus venous diameter increases the blood flow to the heart.22 This 
is eventually followed by a higher umbilical artery blood flow resist‐
ance and a decrease in cerebral artery resistance.23 Subsequently, 
changes in the pulmonary arteries can be observed, such as a higher 
pulmonary TVI.24	For	the	current	study,	we	hypothesized	that	fetal	
umbilical, cerebral, and pulmonary blood flow adaptations may af‐
fect growth and maturation of the airways and lungs, which predis‐
pose individuals to lung disease.8,9
Fetal	blood	flow	adaptations	are	related	to	fetal	growth	restric‐
tion or low birthweight with further consequences for childhood 
 Study population
Late/persistent 13.3 (120)
Missing 17.8 (161)
Age at follow‐up, y 9.8 (9.1‐10.5)
Body	mass	index	at	age	10	y	
(kg/m2)
17.1 (2.2)
Ever eczema at age 10 y (%)
No 73.9 (667)
Yes 26.1 (236)
Inhalant allergic sensitization at age 10 y (%)
No 67.7 (611)
Yes 32.3 (292)
Current asthma (%)
No 88.7 (801)
Yes 3.7 (33)
Missing 7.6 (69)
FEV1 (L/s) 2.05 (0.29)
FVC	(L) 2.39 (0.35)
FEV1/FVC 0.86 (0.06)
Values are means (standard deviation), medians (95% range), or valid per‐
centages (absolute numbers). Data were not imputed for the third trimes‐
ter,	 birth	 characteristics,	 and	 respiratory	 outcomes.	 FEV1, forced 
expiratory	volume	in	1	s;	FVC,	forced	vital	capacity;	NI,	not	imputed;	PI,	
pulsatility	index.
TA B L E  1   (Continued)
TA B L E  2   Associations of third‐trimester fetal blood flow with wheezing patterns until the age of 6 y (adjusted model)
 
Never wheezing 
Odds ratio (95% CI)  
(n = 414)
Early wheezing 
Odds ratio (95% CI) 
(n = 208)
Late or persistent 
wheezing 
Odds ratio (95% CI)  
(n = 120)
Overall wheezing 
Odds ratio (95% CI)  
(n = 386)
Umbilical artery PI (n = 884) Reference 2.07 (0.70, 6.10) 1.68 (0.34, 6.50) 1.61 (0.92, 2,83)
Middle cerebral artery PI (n = 877) Reference 0.77 (0.46, 1.31) 1.08 (0.56, 2.05) 1.06 (0.81, 1.39)
Umbilical/middle cerebral artery 
ratio (n = 858)
Reference 2.74 (0.60, 12.62) 0.96 (0.14, 6.80) 1.07 (0.48, 2.41)
Pulmonary artery time velocity 
integral (n = 788)
Reference 1.01 (0.91, 1.12) 1.14 (1.01, 1.29)*  1.03 (0.98, 1.08)
Values are odds ratios (95% confidence intervals) from logistic regression models and generalized estimating equation models (overall wheezing; 
wheezing	on	at	least	one	time	point).	“n”	represents	number	of	cases.	Models	were	adjusted	for	maternal	educational	level,	parity,	body	mass	index,	
smoking,	folic	acid	use,	pregnancy	complications	and	gestational	age	at	third	trimester,	estimated	fetal	weight,	and	child	sex.	PI,	pulsatility	index.
*P < 0.05.
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respiratory health.12 Umbilical placental embolization in sheep was 
associated with structural alterations in the lungs, such as fewer 
but larger alveoli and a 10% reduction in the internal surface area.9 
Another animal study did not find differences in lung growth after 
umbilical placental embolization, but did find higher pulmonary de‐
oxyribonucleic	 acid	 and	 plasma	 cortisol	 levels	 suggesting	 that	 the	
offspring lungs remain underdeveloped during life.25 Children born 
with a very low birthweight or preterm are at higher risks of severe 
chronic respiratory diseases, such as bronchopulmonary dysplasia 
(BPD).26 Intrauterine conditions such as abnormal placental flow or 
suboptimal development of the placenta may lead to an increased 
expression	of	angiogenic	 factors,	 such	as	soluble	 fms‐like	 tyrosine	
kinase‐1 and vascular endothelial growth factor, which increases the 
risk of chronic respiratory diseases in childhood.27,28 Also, an ele‐
vated inflammation status, found in growth restricted fetuses, could 
lead to reduced lung function later in life.29 Impaired vasculogenesis 
and angiogenesis, found in children with intrauterine growth restric‐
tion, might be other mechanisms than structural lung growth alter‐
ations leading to a suboptimal lung development.30 Children with 
fetal growth restriction might be vulnerable to more adaptive pro‐
cesses and have increased risk of respiratory morbidity in later life. 
Furthermore,	 maternal	 hypertensive	 disorders	 during	 pregnancy	
could have an effect on respiratory morbidity through multiple un‐
derlying mechanisms such as a disturbed placental blood flow and an 
altered angiogenic status. Previously published studies have shown 
that hypertensive disorders in pregnancy might be related to lower 
lung function in newborn infants or increased risk of wheezing.31,32 
A recent study from the same cohort as the current study reported 
associations for blood pressure across the full range in different 
trimesters with asthma‐related outcomes in childhood, but not for 
maternal hypertensive disorders with these outcomes.34 The role 
of fetal blood flow patterns for these associations is not clear. Our 
observed associations were not mediated through birthweight or 
gestational age at birth, but a possible role of the placenta or inflam‐
matory status of the newborn warrants further studies.
Our	study	resulted	mainly	in	negative	findings,	with	two	excep‐
tions.	First,	our	results	showed	that	an	increase	in	TVI	was	related	
to late/persistent wheezing. An increased TVI might be a sign of 
underdevelopment of the fetal airways, such as fewer but larger al‐
veoli and impaired growth of the airways and lungs.8,9 This finding 
might suggest that pulmonary blood flow in fetal life might be re‐
lated to an increased risk of late/persistent wheezing in later life. A 
higher	middle	cerebral	artery	PI	was	associated	with	a	higher	FEV1/
FVC.	Our	 results	 showed	 a	 non‐significant	 inverse	 relation	 of	 the	
middle	cerebral	artery	PI	with	FVC,	but	no	association	was	observed	
for	FEV1.	We	speculate	that	flow	patterns	related	to	fetal	brain	spar‐
ing might have consequences for the growth of the lungs. However, 
as no other effects of fetal blood flow measures on lung function or 
asthma in childhood were found, the observed association might be 
a chance finding.
4.2 | Strengths and limitations
The main strength of this study was the large population‐based co‐
hort	examined	 from	 fetal	 life	onward.	To	our	knowledge,	 this	 is	 the	
first	 study	 to	examine	 the	effects	of	 fetal	blood	 flow	on	 respiratory	
outcomes. The population‐based setting enabled us to assess the 
fetal blood flow across the full range, rather than only in fetuses with 
growth	 restriction	 or	 other	 complications.	 Follow‐up	measurements	
at the age of 10 years were available in 74% of the children. Missing 
information about wheezing, lung function, or asthma could lead to 
selection bias and loss of power. Our results would be biased if the 
associations between fetal blood flow and wheezing, lung function, 
or asthma differed between those included and those not included 
in	 the	study.	Although	this	seems	unlikely,	 it	cannot	be	excluded.	 In	
the present study, we evaluated multiple associations. However, be‐
cause of the correlations between the outcome measures, we did not 
correct for multiple testing. Our results were inconsistent and the as‐
sociations might be a chance finding. In this study, there might have 
occurred some bias toward a more affluent and healthy population 
due to differences in characteristics between those lost to follow‐
up and included in the study.13 Information on wheezing patterns, 
asthma, and eczema was obtained by questionnaires, adapted from 
the ISAAC‐Core questionnaires. These have been validated and shown 
adequate for epidemiological studies.35 However, misclassification 
due	to	under‐	or	overreporting	cannot	be	excluded.	Finally,	although	
TA B L E  3   Associations of third‐trimester fetal blood flow with lung function and asthma at age 10 y (adjusted model)
 
FEV1 
Z‐score (95% CI) 
(n = 785)
FVC 
Z‐score (95% CI) 
(n = 785)
FEV1/FVC 
Z‐score (95% CI) 
(n = 785)
Current asthma 
Odds ratio (95% CI) 
(n = 834)
Umbilical artery PI (n = 884) −0.06	(−0.46,	0.33) −0.23	(−0.61,	0.14) 0.32	(−0.09,	0.74) 2.54 (0.26, 24.59)
Middle cerebral artery PI (n = 877) 0.01	(−0.18,	0.20) −0.10	(−0.28,	0.08) 0.21 (0.01, 0.42)*  0.83 (0.28, 2.44)
Umbilical/middle cerebral artery ratio (n = 858) −0.16	(−0.73,	0.41) −0.20	(−0.74,	0.34) 0.09	(−0.52,	0.69) 0.84 (0.03, 23.28)
Pulmonary artery time velocity integral (n = 788) 0.01	(−0.03,	0.05) 0.02	(−0.01,	0.06) −0.04	(−0.08,	0.01) 1.08 (0.88, 1.34)
Values are z‐score differences or odds ratios (95% confidence intervals) and reflect the change in lung function or risk for asthma per change in fetal 
blood	flow.	Lung	function	variables	were	converted	into	sex‐,	height‐,	age‐,	and	ethnicity‐adjusted	z‐scores.	Models	were	adjusted	for	maternal	educa‐
tional	level,	parity,	body	mass	index,	smoking,	folic	acid	use,	pregnancy	complications	and	gestational	age	at	third	trimester,	estimated	fetal	weight,	and	
child	sex.	FEV1,	forced	expiratory	volume	in	1	s;	FVC,	forced	vital	capacity;	PI,	pulsatility	index.
*P < 0.05.
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we had information about a large number of confounders, the influ‐
ence of residual confounding should be considered, as in any obser‐
vational study.
4.3 | Conclusion and perspectives
The results of our study are important from an etiological perspec‐
tive. Our findings suggest that adaptations in fetal blood flow might 
contribute to the risk of wheezing and lung function in childhood. 
However, the observed effects were small or non‐significant and 
may reflect subclinical changes only. These findings should be con‐
sidered as hypothesis generating and need further replication.
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